Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of X4 Pharmaceuticals Inc (NASDAQ: XFOR) closed at $0.70 in the last session, up 1.04% from day before closing price of $0.69. In other words, the price has increased by $1.04 from its previous closing price. On the day, 0.73 million shares were traded. XFOR stock price reached its highest trading level at $0.7144 during the session, while it also had its lowest trading level at $0.6702.
Ratios:
We take a closer look at XFOR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.07. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.82.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 12, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $3 previously.
On December 22, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on December 22, 2022, with a $3 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 11 ’24 when Taveras Arthur sold 14,235 shares for $0.88 per share. The transaction valued at 12,552 led to the insider holds 234,301 shares of the business.
Ragan Paula sold 49,678 shares of XFOR for $43,856 on Mar 11 ’24. The President and CEO now owns 765,068 shares after completing the transaction at $0.88 per share. On Mar 11 ’24, another insider, Mostafa Adam S., who serves as the Chief Financial Officer of the company, sold 52,500 shares for $0.88 each. As a result, the insider received 46,347 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XFOR now has a Market Capitalization of 117950000 and an Enterprise Value of 27423660. As of this moment, X4’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.18. For the stock, the TTM Price-to-Sale (P/S) ratio is 210.62 while its Price-to-Book (P/B) ratio in mrq is 1.25. Its current Enterprise Value per Revenue stands at 48.71 whereas that against EBITDA is -0.223.
Stock Price History:
Over the past 52 weeks, XFOR has reached a high of $1.60, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is -3.78%, while the 200-Day Moving Average is calculated to be -22.64%.
Shares Statistics:
According to the various share statistics, XFOR traded on average about 2.00M shares per day over the past 3-months and 862790 shares per day over the past 10 days. A total of 167.43M shares are outstanding, with a floating share count of 117.62M. Insiders hold about 30.19% of the company’s shares, while institutions hold 38.56% stake in the company. Shares short for XFOR as of 1723680000 were 15374627 with a Short Ratio of 7.69, compared to 1721001600 on 16505651. Therefore, it implies a Short% of Shares Outstanding of 15374627 and a Short% of Float of 9.21.
